Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
AMAmphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ Global Select · Currency in USD
$25.14 ▼ -0.90 (-3.46%)
At close: Oct 23, 4:00 PM ET. Market closed.
$24.90 ▼ -0.24 (-0.95%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$26.04
Open
$25.91
Day's Range
$24.62 – $25.91
52 Week Range
$16.65 – $29.52
Volume
482,286
Avg. Volume
481,799
Market Cap
$1.07B
Beta (5Y Monthly)
0.90
PE Ratio (TTM)
14.45
EPS (TTM)
$1.80
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
$0.30 (1.19%)
Ex-Dividend Date
Jun 11, 2010
1y Target Est
$21.00

Profile: Amphastar Pharmaceuticals, Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
1,976
CEO
Yongfeng Zhang

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate $0.86 · Revenue est. $197.52M
DateEst.Actual
Aug 6, 2026$0.62$0.91Beat
May 7, 2026$0.70$0.42Miss
Feb 26, 2026$0.90$0.73Miss
Nov 6, 2025$0.77$0.93Beat
Aug 7, 2025$0.71$0.85Beat
May 7, 2025$0.66$0.74Beat

Analyst view

Consensus price target
$21.00 ▼ -16.5%
Range $19.00 – $23.00
Rating: Hold
Buy 25% · Hold 67% · Sell 8%

Get free alerts on AMPH and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.